Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Scientific Reports|August 18, 2017
Enhancing Immune Responses to Cancer Vaccines Using Multi-Site InjectionsRobert C Mould, Amanda W K AuYeung, Jacob P van Vloten, et al.
Frontiers in Immunology|December 5, 2022
Multiplex flow cytometry-based assay for quantifying tumor- and virus-associated antibodies induced by immunotherapiesJessica A Minott, Jacob P van Vloten, Jacob G E Yates, et al.
The Journal of Nutritional Biochemistry|February 8, 2018
Marine fish oil is more potent than plant-based n-3 polyunsaturated fatty acids in the prevention of mammary tumorsJiajie Liu, Salma A Abdelmagid, Christopher J Pinelli, et al.
Immunity|October 7, 2008
Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasisZhenyue Hao, Gordon S Duncan, Jane Seagal, et al.
Cancers|December 24, 2021
Using a Prime-Boost Vaccination Strategy That Proved Effective for High Resolution Epitope Mapping to Characterize the Elusive Immunogenicity of SurvivinRobert C Mould, Jacob P van Vloten, Amanda W K AuYeung, et al.
Nutrients|February 27, 2026
Lifelong n-3 PUFA Consumption Reduces HER2+ Mammary Tumour Growth and Alters Immune Markers Compared to Safflower- or Corn Oil-Based Sources of n-6 PUFARahbika Ashraf, Connor D C Buchanan, Lyn M Hillyer, et al.
Molecular Therapy Oncolytics|December 11, 2023
Kinetic analysis of oncolytic OrfV-induced innate and adaptive immune responses in a murine model of late-stage ovarian cancerJessica A Minott, Jacob P van Vloten, Jake G E Yates, et al.
Analytical Biochemistry|December 17, 2025
Towards canine immunotherapy models: Monoclonal antibodies with redox regulated epitopes targeting TIM3 attenuate Galectin-9 bindingJack Brydon, Radovan Krejcir, Mariana Grima, et al.
International Journal of Cancer|June 9, 2004
Polygenic control of hepatocarcinogenesis in Copenhagen x F344 ratsMaria R De Miglio, Rosa M Pascale, Maria M Simile, et al.
The American Journal of Pathology|July 20, 2024
Cardiac Atrophy, Dysfunction, and Metabolic Impairments: A Cancer-Induced Cardiomyopathy PhenotypeLeslie M Ogilvie, Luca J Delfinis, Bridget Coyle-Asbil, et al.
Pageof 9